Page last updated: 2024-11-12

secoisolariciresinol diglucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

secoisolariciresinol diglucoside: major precursor of mammalian lignans; structure given in first source; RN given refers to B-D-GLUCO isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9917980
CHEMBL ID2425486
SCHEMBL ID16307898
MeSH IDM0238232

Synonyms (34)

Synonym
secoisolariciresinol diglucoside
2,3-bis(3-methoxy-4-hydroxybenzyl)butane-1,4-diol 1,4-diglucoside
bmhb-diglc
S3780
158932-33-3
CHEMBL2425486
SCHEMBL16307898
AC-34917
(2r,2'r,3s,3's,4s,4's,5r,5'r,6r,6'r)-6,6'-(((2r,3r)-2,3-bis(4-hydroxy-3-methoxybenzyl)butane-1,4-diyl)bis(oxy))bis(2-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol)
secoisolariciresinol-diglucoside
DTXSID40432760 ,
SDG ,
secoisolarisiresinol diglucoside
t9281l29mv ,
.beta.-d-glucopyranoside, (2r,3r)-2,3-bis((4-hydroxy-3-methoxyphenyl)methyl)-1,4-butanediyl bis-
(2r,3r)-2,3-bis((4-hydroxy-3-methoxyphenyl)methyl)-1,4-butanediyl bis-.beta.-d-glucopyranoside
(2r,3r)-2,3-bis((4-hydroxy-3-methoxyphenyl)methyl)-1,4-butanediyl bis-beta-d-glucopyranoside
unii-t9281l29mv
(r,r)-secoisolariciresinol diglucoside
secoisolariciresinol diglycoside
AKOS030573403
E1451
(2r,3r,4s,5s,6r)-2-[(2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
HY-N6937
Q4161320
secoisolariciresinoldiglucoside
lgm2605
CCG-270376
CS-0100998
MS-31118
(r,r)-sdg
flaxseedligans(sdg)
dtxcid60383588
beta-d-glucopyranoside, (2r,3r)-2,3-bis((4-hydroxy-3-methoxyphenyl)methyl)-1,4-butanediyl bis-

Research Excerpts

Overview

Secoisolariciresinol diglucoside (SDG) is a phytoestrogen rich in food flaxseed, sunflower seeds, and sesame seeds. It has been reported to improve postmenopausal osteoporosis caused by estrogen deficiency.

ExcerptReferenceRelevance
"Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. "( Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis.
Chen, G; Chen, Y; Gao, J; Hong, J; Xu, Z, 2023
)
3.8
"Secoisolariciresinol diglucoside (SDG) is a phytoestrogen and rich in food flaxseed, sunflower seeds, and sesame seeds. "( Secoisolariciresinol Diglucoside Delays the Progression of Aging-Related Diseases and Extends the Lifespan of
Chen, JN; Lu, M; Luo, HR; Tan, L; Wu, GS; Yang, ZL; Zhou, XG; Zhu, Q, 2020
)
3.44
"Secoisolariciresinol diglucoside is a flaxseed lignan and is metabolized to mammalian lignans by the gut."( Secoisolariciresinol diglucoside induces caspase-3-mediated apoptosis in monolayer and spheroid cultures of human colon carcinoma cells.
Bayram, D; Özgöçmen, M; Şahin Calapoğlu, N; Toğay, VA; Yavuz Türel, G, 2021
)
2.79
"Secoisolariciresinol diglucoside (SDG) is a main substance of lignan which belongs to the phytoestrogen family and exists abundantly in flaxseeds."( Secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway.
Jin, JS; Jung, Y; Kang, J; Kim, HL; Kwak, HJ; Lim, S; Park, H; Park, J; Song, G; Um, JY; Youn, DH, 2018
)
2.64
"Secoisolariciresinol diglucoside (SDG) is a lignan found in high concentration in flaxseed that may have selective estrogen receptor modulator-like effects resulting in antiestrogenic activity in a high estrogen environment."( Effects of Flaxseed Lignan Secoisolariciresinol Diglucosideon Preneoplastic Biomarkers of Cancer Progression in a Model of Simultaneous Breast and Ovarian Cancer Development.
Delman, DM; Fabian, CJ; Kimler, BF; Petroff, BK; Yeh, H, 2015
)
1.44
"Secoisolariciresinol diglucoside (SDG) is a non-toxic, flaxseed-derived pluripotent compound that has antioxidant properties and may thus function as a chemopreventive agent for asbestos-induced mesothelioma."( Asbestos Induces Oxidative Stress and Activation of Nrf2 Signaling in Murine Macrophages: Chemopreventive Role of the Synthetic Lignan Secoisolariciresinol Diglucoside (LGM2605).
Albelda, SM; Christofidou-Solomidou, M; Pietrofesa, RA; Velalopoulou, A, 2016
)
1.36
"Secoisolariciresinol diglucoside (SDG) is an important dietary lignan that is found at very high levels in flaxseed (1-4 %, w/w). "( Dietary secoisolariciresinol diglucoside and its oligomers with 3-hydroxy-3-methyl glutaric acid decrease vitamin E levels in rats.
Aman, P; Budek, A; Eliasson, C; Frank, J; Kamal-Eldin, A; Leroy-Nivard, D; Lundh, T; Vessby, B, 2004
)
2.2
"Secoisolariciresinol diglucoside (SDG) is a plant lignan isolated from flaxseed. "( Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed.
Prasad, K, 1999
)
1.97

Effects

ExcerptReferenceRelevance
"Secoisolariciresinol diglucoside (SDG) has a strong anti-inflammatory effect, which depends partly on the participation of gut microbiota. "( Secoisolariciresinol diglucoside ameliorates high fat diet-induced colon inflammation and regulates gut microbiota in mice.
Han, W; Lan, Y; Li, J; Liu, X; Wang, Y; Yang, Y; Zhang, L, 2022
)
3.61

Toxicity

ExcerptReferenceRelevance
" Treatment with flaxseed hull extract did not lead to adverse effects compared with placebo."( Efficacy and safety of a flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia: a parallel, randomized, double-blind, placebo-controlled, pilot study.
Chaudhary, J; Simons, R; Sonawane, N; Verbruggen, M, 2015
)
0.42

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic parameters and urinary excretion of enterodiol and enterolactone were evaluated after consumption of their purified plant precursor, secoisolariciresinol diglucoside (SDG)."( Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside.
Arts, IC; Hollman, PC; Kuijsten, A; Vree, TB, 2005
)
0.75
" These data suggest a similar pharmacokinetic profile between the enriched and polymer form of SDG, providing support for the use of SDG polymer as a more economical precursor for SECO, ED, and EL in applications of chronic disease management."( Oral Pharmacokinetics of Enriched Secoisolariciresinol Diglucoside and Its Polymer in Rats.
Alcorn, J; Guo, Y; Mustafa, R; Purdy, SK; Reaney, MJT; Shen, J; Tse, TJ; Yang, X, 2021
)
0.9

Compound-Compound Interactions

ExcerptReferenceRelevance
"To study the influence of Secoisolariciresinol Diglucoside (SDG) combined with Bortezomib on induction of apoptosis in lung cancer cell line A549 and its relative mechanisms."( [Effects of secoisolariciresinol diglucoside combined with bortezomib on induction of apoptosis in lung cancer cell line A549].
Li, XW; Yang, JR, 2012
)
1.06
"The results demonstrate that SDG combined with Bortezomib can significantly induce apoptosis of A549 cells, its mechanisms may be involved in activation of the JNK pathway."( [Effects of secoisolariciresinol diglucoside combined with bortezomib on induction of apoptosis in lung cancer cell line A549].
Li, XW; Yang, JR, 2012
)
0.76

Bioavailability

ExcerptReferenceRelevance
" Bioavailability of lignans is influenced by the food matrix and gut microbial action, of which the latter is subject to a large interindividual variation."( Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem.
Eeckhaut, E; Keukeleire, DD; Possemiers, S; Struijs, K; Verstraete, W; Vincken, JP, 2008
)
0.35
" These results indicate that SDG hydrolysis is not a common feature in Bifidobacterium genus, but selected probiotic strains can be combined to β-glucoside-based prebiotics to enhance the release of SECO, thus improving its bioavailability for absorption by colonic mucosa and/or the biotransformation to ED and EL by other intestinal microorganisms."( Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside.
Amaretti, A; Leonardi, A; Raimondi, S; Roncaglia, L; Rossi, M, 2011
)
0.62
"Consumption of flaxseed lignans is associated with various health benefits; however, little is known about the bioavailability of purified lignans in flaxseed."( Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.
Alcorn, J; Krol, ES; Muir, AD; Mukker, JK; Singh, RS, 2015
)
0.42
" The extent of SDG release from the polymer and subsequent bioavailability of SDG metabolites are unknown."( Oral Pharmacokinetics of Enriched Secoisolariciresinol Diglucoside and Its Polymer in Rats.
Alcorn, J; Guo, Y; Mustafa, R; Purdy, SK; Reaney, MJT; Shen, J; Tse, TJ; Yang, X, 2021
)
0.9

Dosage Studied

ExcerptRelevanceReference
" Fasting blood samples (12 h) were collected predose and at the end of the dosing period for serum lipid analyses."( Effects of the flaxseed lignans secoisolariciresinol diglucoside and its aglycone on serum and hepatic lipids in hyperlipidaemic rats.
Alcorn, J; Felmlee, MA; Krol, ES; Muir, AD; Simko, E; Woo, G, 2009
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
(+)-secoisolariciresinol diglucoside biosynthesis16

Bioassays (15)

Assay IDTitleYearJournalArticle
AID771137Antioxidant activity assessed as DPPH radical scavenging activity incubated for 20 mins under dark condition by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID771144Antioxidant activity assessed as reduction of K3FeCN6 at 1 to 500 uM by spectrophotometric analysis in presence of FeCl32013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID771141Antioxidant activity assessed as hydroxyl radical scavenging activity at 8 uM to 1 mM by fluorescence assay relative to gallic acid2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID771136Ratio of ascorbic acid acid EC50 to compound EC50 for reduction of K3FeCN62013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID771140Antioxidant activity assessed as trolox equivalents of peroxyl radical scavenging activity by fluorescence assay2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID771139Antioxidant activity assessed as peroxyl radical scavenging activity at 8 uM to 1 mM by fluorescence assay relative to trolox2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID1064762Apparent permeability across basolateral to apical side in human Caco2 cells after 2 hrs by HPLC analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells.
AID771142Antioxidant activity assessed as gallic acid equivalents of hydroxyl radical scavenging activity by fluorescence assay2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID1064763Apparent permeability across apical to basolateral side in human Caco2 cells after 2 hrs by HPLC analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells.
AID771143Antioxidant activity assessed as reduction of K3FeCN6 by spectrophotometric analysis in presence of FeCl32013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID1064755Stability in HBSS after 48 hrs2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells.
AID1064758Drug metabolism assessed as Helix pomatia beta-glucuronidase/sulfatase type H-5-mediated secoisolariciresinol formation in 48 hrs compound-treated human Caco2 cell lysate prior to enzyme addition measured up to 48 hrs by HPLC analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells.
AID771135Ratio of alpha-tocopherol EC50 to compound EC50 for reduction of K3FeCN62013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID771138Antioxidant activity assessed as DPPH radical scavenging activity at 5 to 500 uM incubated for 20 mins under dark condition by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Oct-01, Volume: 23, Issue:19
Synthesis and antioxidant evaluation of (S,S)- and (R,R)-secoisolariciresinol diglucosides (SDGs).
AID1064759Drug metabolism in human Caco2 cells assessed as compound glucuronidation/sulfation at 100 uM after 48 hrs by HPLC analysis2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (154)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (6.49)18.2507
2000's50 (32.47)29.6817
2010's67 (43.51)24.3611
2020's27 (17.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.49 (24.57)
Research Supply Index5.13 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index96.25 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials9 (5.66%)5.53%
Reviews9 (5.66%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other141 (88.68%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]